Drinking-water 4,4′-methylenedianiline establishes a longitudinally tractable mouse model of cholestatic liver injury
Toxicological Sciences · 02.11.2026 · 209 (11)
DOI: 10.1093/toxsci/kfag142 ↗Kurz gefasst
Fachartikel in der Zeitschrift Toxicological Sciences, online erschienen am 02.11.2026. Verfasst von Takumi Iwasaka und 8 weiteren Autor:innen. Beteiligte Einrichtung: Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo 113-0033, Japan. Hauptthemen laut MEDLINE: Disease Models, Animal, Drinking Water, Chemical and Drug Induced Liver Injury, Aniline Compounds. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: JSPS KAKENHI.
Abstract (Originalsprache)
Longitudinal studies of liver injury require models that can be maintained with simple administration, low procedure-related stress, and acceptable survival. Drinking-water thioacetamide (TAA-DW) is useful for this purpose, but it mainly produces centrilobular hepatocellular injury. Few drinking-water models are available for cholestatic liver injury. Here, we tested whether 4,4′-methylenedianiline (MDA), a known bile-duct-damaging hepatotoxicant, can be used to build a practical drinking-water model of cholestatic liver injury in mice. Male C57BL/6JJcl mice received MDA in drinking water for up to 28 d. A route- and administration-schedule-matched TAA-DW model was used as a reference. Drinking-water MDA (MDA-DW) caused sustained ALT elevation without observed mortality under the tested regimen. Compared with TAA-DW, MDA-DW produced stronger cholestatic biochemical features, including increased ALP, TBIL, and TCHO. Histology showed bile duct hyperplasia with degeneration, periportal/peribiliary fibrosis, and scattered focal hepatocellular necrosis. Whole-slide image analysis supported the distinct lesion distribution between MDA-DW and TAA-DW. Early time-resolved multimodal profiling showed model-specific responses: MDA-DW showed ALT elevation around Days 2 to 3, increased CD8-positive T cells on Day 8, and enrichment of fibrinolysis-related gene sets, whereas TAA-DW showed a sharp early injury peak and transient eosinophil increase. Impact Statement: This study expands the range of drinking-water liver injury models by providing a low-mortality MDA-DW model with cholestatic liver injury. The model offers a simple platform for time-resolved studies of liver injury progression, tissue remodeling, and model-specific inflammatory responses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo 113-0033, Japan.
- Laboratory for Drug Discovery and Development, SHIONOGI & Co., Ltd, Osaka 561-0825, Japan.
ORCID-Profile: Yuki Kato, Tadahaya Mizuno
Förderung
- JSPS KAKENHI
Zitieren
APA
Iwasaka, T., Morita, K., Azuma, I., Nakagawa, T., Nakashima, E., Kamei, T., Kato, Y., Kusuhara, H., & Mizuno, T. (2026). Drinking-water 4,4′-methylenedianiline establishes a longitudinally tractable mouse model of cholestatic liver injury. Toxicological Sciences, 209(11). https://doi.org/10.1093/toxsci/kfag142
Vancouver
Iwasaka T, Morita K, Azuma I, Nakagawa T, Nakashima E, Kamei T, et al. Drinking-water 4,4′-methylenedianiline establishes a longitudinally tractable mouse model of cholestatic liver injury. Toxicological Sciences. 2026;209(11). doi:10.1093/toxsci/kfag142
BibTeX
@article{Iwasaka2026,
author = {Iwasaka, Takumi and Morita, Katsuhisa and Azuma, Iori and Nakagawa, Tomoka and Nakashima, Eri and Kamei, Tomomi and Kato, Yuki and Kusuhara, Hiroyuki and Mizuno, Tadahaya},
title = {Drinking-water 4,4′-methylenedianiline establishes a longitudinally tractable mouse model of cholestatic liver injury},
journal = {Toxicological Sciences},
year = {2026},
volume = {209},
number = {11},
doi = {10.1093/toxsci/kfag142}
}
EUVIMED